GPT and fatty liver disease: Changes in hepatic and inflammatory markers ind the blood such as ALT, hs-CRP, TNFa; changes in hepatic fat content, assessed by MR spectroscopy; changes in hepatic steatosis and inflammation, assessed histologically; changes in the expression of proteins in the relevant inflammatory pathways, assessed by gene expression studies.